Role of Protease-Activated Receptor-1 in Endothelial Nitric Oxide Synthase-Thr495 Phosphorylation
- 1 February 2009
- journal article
- other
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 234 (2), 132-139
- https://doi.org/10.3181/0807-rm-233
Abstract
Protease activated receptors (PARs) are G protein-coupled receptors that are known to regulate endothelial nitric oxide synthase (eNOS) activity in part by phosphorylating the enzyme at various sites. Ser1177 is a positive regulatory site, which leads to the enhanced production of nitric oxide (NO), a vasodilator of arteries. Thr495 is a negative regulatory site, which inhibits NO production. We have shown that thrombin, a PAR agonist, mediates eNOS-Ser1177 phosphorylation through Gq and a calcium and protein kinase C (PKC)-δ sensitive, but phosphatidylinositol 3-kinase (PI3K)/Akt-independent pathway. However, the mechanism for eNOS-Thr495 phosphorylation by PAR agonists is unknown. We used a specific synthetic PAR-1 activating peptide, TFLLR, and thrombin to assess the role of PAR-1 involvement in the phosphorylation of eNOS-Thr495 in human umbilical vein endothelial cells (HUVECs). Using Western blot analysis and the Griess Reagent assay, we found that both agonists phosphorylated Thr495 in a time- and dose-dependent manner and significantly decreased nitrite production, respectively. Pretreatment of cells with the PAR-1 inhibitor, SCH-79797, resulted in a significant decrease in thrombin- and TFLLR-induced phosphorylation of eNOS-Thr495 and an increase in nitrite production. We further demonstrated that inhibition of Rho with C3 exoenzyme or dominant negative (dn) RhoA, and inhibition of Rho-Kinase (ROCK) with Y-27632 caused a significant decrease in thrombin and TFLLR-induced Thr495 phosphorylation. Blockade of the Rho/ROCK pathway also caused an increase in nitrite production. This suggests that PAR-1 regulates eNOS activity via phosphorylation of eNOS-Thr495, which is dependent upon activation of the Rho/ROCK pathway. These findings will be beneficial in further understanding the signaling pathways that regulate eNOS-induced NO production, which plays an important role in endothelial dysfunction associated with cardiovascular disease.Keywords
This publication has 15 references indexed in Scilit:
- Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cellsBiochemical and Biophysical Research Communications, 2007
- Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseJournal of Hepatology, 2007
- Regulation of Endothelial Nitric Oxide Synthase by ThrombinHypertension, 2007
- FK506 Binding Protein 12/12.6 Depletion Increases Endothelial Nitric Oxide Synthase Threonine 495 Phosphorylation and Blood PressureHypertension, 2007
- The Roles of Proteinase-Activated Receptors in the Vascular Physiology and PathophysiologyArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- The Cardiovascular Actions of Protease-Activated ReceptorsMolecular Pharmacology, 2004
- Thrombin and Phenotypic Modulation of the EndotheliumArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial CellsMolecular and Cellular Biology, 2002
- Bradykinin-regulated Interactions of the Mitogen-activated Protein Kinase Pathway with the Endothelial Nitric-oxide SynthaseOnline Journal of Public Health Informatics, 2000
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987